Complete Cytogenetic Response, Not Deep Molecular Response, Is Associated With Survival in Chronic Myeloid Leukemia Reply

被引：2
|
作者：
Hehlmann, Ruediger [1 ]
Hasford, Joerg [2 ]
Pfirrmann, Markus [2 ]
Lauseker, Michael [2 ]
Saussele, Susanne [1 ]
Hochhaus, Andreas [3 ]
机构：
[1] Heidelberg Univ, Univ Med Mannheim, Mannheim, Germany
[2] Univ Munich, Inst Med Informat Verarbeitung Biomet & Epidemiol, Munich, Germany
[3] Univ Klinkum Jena, Jena, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 27期
关键词：
KINASE INHIBITOR THERAPY; RECOMMENDATIONS; IMATINIB;
D O I：
10.1200/JCO.2014.56.3908
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3078 / +
页数：2
相关论文
共 50 条
  • [1] Complete Cytogenetic Response, Not Deep Molecular Response, Is Associated With Survival in Chronic Myeloid Leukemia
    Kantarjian, Hagop
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3077 - 3077
  • [2] Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate
    Espinet, Blanca
    Carla Oliveira, Ana
    Boque, Concepcion
    Domingo, Alicia
    Alonso, Esther
    Sole, Francesc
    HAEMATOLOGICA, 2005, 90 (04) : 556 - 558
  • [3] Predictive value of early molecular response for deep molecular response in chronic phase of chronic myeloid leukemia
    Wang, Rui
    Cong, Yue
    Li, Caili
    Zhang, Chen
    Lin, Hai
    MEDICINE, 2019, 98 (15)
  • [4] Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
    Okamoto, Yuji
    Hirano, Mitsuhito
    Morino, Kai
    Kajita, Masashi K.
    Nakaoka, Shinji
    Tsuda, Mayuko
    Sugimoto, Kei-ji
    Tamaki, Shigehisa
    Hisatake, Junichi
    Yokoyama, Hisayuki
    Igarashi, Tadahiko
    Shinagawa, Atsushi
    Sugawara, Takeaki
    Hara, Satoru
    Fujikawa, Kazuhisa
    Shimizu, Seiichi
    Yujiri, Toshiaki
    Wakita, Hisashi
    Nishiwaki, Kaichi
    Tojo, Arinobu
    Aihara, Kazuyuki
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2022, 8 (01)
  • [5] Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?
    Branford, Susan
    HAEMATOLOGICA, 2020, 105 (12) : 2730 - 2737
  • [6] Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
    Hanfstein, B.
    Mueller, M. C.
    Hehlmann, R.
    Erben, P.
    Lauseker, M.
    Fabarius, A.
    Schnittger, S.
    Haferlach, C.
    Goehring, G.
    Proetel, U.
    Kolb, H-J
    Krause, S. W.
    Hofmann, W-K
    Schubert, J.
    Einsele, H.
    Dengler, J.
    Haenel, M.
    Falge, C.
    Kanz, L.
    Neubauer, A.
    Kneba, M.
    Stegelmann, F.
    Pfreundschuh, M.
    Waller, C. F.
    Branford, S.
    Hughes, T. P.
    Spiekermann, K.
    Baerlocher, G. M.
    Pfirrmann, M.
    Hasford, J.
    Saussele, S.
    Hochhaus, A.
    LEUKEMIA, 2012, 26 (09) : 2096 - 2102
  • [7] Factors predicting molecular and cytogenetic response in chronic myeloid leukemia patients treated with imatinib
    Roche-Lestienne, C
    Darré, S
    Laï, DL
    Facon, T
    Guilhot, J
    Preudhomme, C
    HAEMATOLOGICA, 2005, 90 (01) : 131 - 133
  • [8] Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia
    Dragani, Matteo
    Rege-Cambrin, Giovanna
    Ferrero, Dario
    Abruzzese, Elisabetta
    Pregno, Patrizia
    Elena, Chiara
    Cedrone, Michele
    Santoro, Marco
    Andreani, Giacomo
    Saglio, Giuseppe
    Fava, Carmen
    LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3330 - 3332
  • [9] Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia
    Miglino, Maurizio
    Grasso, Raffaella
    Varaldo, Riccardo
    Fugazza, Giuseppina
    Colombo, Nicoletta
    Clavio, Marino
    Canepa, Letizia
    Garuti, Anna
    Ibatici, Adalberto
    Pierri, Ivana
    Ballerini, Filippo
    Sessarego, Mario
    Gobbi, Marco
    LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1348 - 1351
  • [10] Monitoring Molecular Response in Chronic Myeloid Leukemia
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop M.
    CANCER, 2011, 117 (06) : 1113 - 1122
12345